Cami Samuels News Today

Novel collaboration by all-star team of university technology transfer experts, venture capitalists, and law firms gives life sciences start-ups a jump start Collaboration will benefit life sciences entrepreneurs aiming to launch start-ups based on their discoveries and innovations Streamlining the path to life sciences deals will also lead to overall improvement in healthcare options for…

12th annual life sciences event covered ground ranging from the pipeline of potential new treatments to the fund raising prospects for startups

January 28, 2021 | The Brief The Brief: Opportunity Zone window, executive climate orders, minority-led fund managers, solar in Chile, peer selection, beacon for impact entrepreneurs The team at Featured: Policy Corner Opportunity Zone deals flow as investors eye new rules. The Trump administration touted Opportunity Zones among its policy achievements. President Biden is proposing changes to make them work better for Black and Brown communities and small businesses. Impact investors aren’t...

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Cami Samuels is a partner at Venrock and focuses on healthcare. She served on the board of Corvidia, a biotech company that was acquired in a $725 million cash deal in June 2020. A veteran of the industry, Samuels shares common themes of successful mergers and acquisitions from her 20 years of experience as a VC. Dont build your company for M&A because youll g...